2290.0000 14.00 (0.62%)
NSE Aug 12, 2026 15:31 PM
Volume: 464.6K
 

Geojit BNP Paribas
Glenmark Pharmaceuticals Ltd, which has a presence in over 80 countries, focuses on the generics, specialty and over-the-counter (OTC) segments, with a strong presence in diabetes, cardiovascular and oral contraceptives....
Deven Choksey increased Accumulate price target of Glenmark Pharmaceuticals Ltd. to 2563.0 on 07 Aug, 2026.
More from Glenmark Pharmaceuticals Ltd.
Recommended